CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

BofA Securities Adjusts Gilead Sciences Price Target to $168 From $162, Maintains Buy Rating

Positive
AI Analysis

Summary

BofA Securities raised its price target for Gilead Sciences from $162 to $168 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.30
Price TargetRatingAnalyst Update
Related Companies

Read the original article

Published by yahoo_finance on October 12, 2026 12:07 PM

Read Original